A new, highly contagious COVID-19 variant, NB.1.8.1, has been identified and is actively circulating, with significant detection across California and concerns mounting among health experts. This emerging sub-strain, first pinpointed by scientists at Stanford University, originated in China and has swiftly made its way to the United States and Europe. As public health policies evolve and immunity wanes, understanding the characteristics of NB.1.8.1 and implementing robust preventive measures is more crucial than ever for protecting yourself and your loved ones. This comprehensive guide synthesizes expert insights and the latest data to keep you informed.
Unpacking NB.1.8.1: What We Know About the New Variant
NB.1.8.1 is an Omicron-lineage subvariant that has garnered the attention of the World Health Organization (WHO), which is actively monitoring its global spread. While not yet meeting the CDC’s 1% threshold for inclusion on their variant dashboard, its presence is undeniable, detected in wastewater samples across California’s Bay Area and in states like Arizona, Rhode Island, and Ohio. This variant’s key characteristic is its enhanced transmissibility.
Infectious disease experts, including Dr. John Swartzberg of UC Berkeley, highlight that NB.1.8.1 has a greater ability to attach to human cell receptor sites, explaining its increased contagiousness. The good news, as confirmed by both Dr. Swartzberg and the WHO, is that NB.1.8.1 does not appear to be more virulent than previous strains, meaning it is not associated with more severe illness. Despite this, its heightened contagiousness poses a significant risk for driving up overall case numbers, particularly as global and national COVID-19 activity shows fluctuating trends.
The Looming Threat: Why Experts Are Concerned
Despite current low COVID-19 numbers in early 2025, experts are united in their prediction of a potential resurgence, especially during the upcoming fall and winter “respiratory season.” Dr. Arthur Reingold, a UC Berkeley epidemiology professor, warns that increased infections, hospitalizations, and even deaths are a strong likelihood if the variant continues to spread unchecked. This concern is amplified by several factors:
Waning Immunity: Many adults have not received the latest booster, leading to a general decline in population immunity against the evolving virus.
Summer Surges: Contrary to popular belief, respiratory viruses like COVID-19 don’t disappear in warmer months. Federal data already indicates an upward trend in COVID-19 cases and emergency department visits across most U.S. states, partly because people retreat indoors to air-conditioned spaces, facilitating germ spread.
Competing Variants: While NB.1.8.1 gains traction, another variant, XFG (nicknamed “Stratus”), is also prevalent in the U.S. and is known for potentially causing a “razor blade” sore throat. The WHO has designated Stratus as a “variant under monitoring,” noting that existing vaccines remain effective against it.
A critical point of alarm for medical professionals centers on recent policy changes regarding vaccine access and recommendations. Health and Human Services Secretary Robert F. Kennedy Jr. has reportedly removed the COVID-19 vaccine from the CDC’s immunization schedule for pregnant women and healthy children. Additionally, the FDA plans to limit updated COVID-19 shot approvals to older adults and younger individuals with specific medical conditions.
Experts are voicing strong opposition to these shifts. Dr. Swartzberg points out the severe implications for infants, who typically receive crucial protection from COVID-19 antibodies passed on by vaccinated pregnant mothers. He states that “all of this protection is being lost by this decision.” Dr. Thomas Russo of the University at Buffalo further cautions that such policy changes could leave pregnant individuals and children under five years old particularly vulnerable to severe outcomes this winter. The American Academy of Pediatrics, in contrast, continues to endorse COVID-19 vaccinations for children aged 6 months and older, underscoring the divide in public health guidance.
Safeguarding Your Health: Vaccination and Prevention Strategies
Given the continued evolution of the COVID-19 virus and the emergence of new variants like NB.1.8.1, maintaining vigilance and adopting effective public health strategies remain paramount.
The Role of Vaccination and Boosters
Despite new variants, current vaccination strategies offer a robust defense. NB.1.8.1 is considered a “cousin” of JN.1, the target of the most recent booster, suggesting that existing vaccination should still provide a degree of protection. Furthermore, the FDA has requested drugmakers to update fall COVID-19 vaccines to target the LP.8.1 variant, with promising data from Pfizer and Moderna indicating these updated vaccines would also offer protection against NB.1.8.1.
Infectious disease specialists like Dr. Swartzberg and Dr. Reingold personally advocate for continued vaccination, with Dr. Reingold confirming his intent to get a booster shot and recommending it to friends and family.
Timing Your Booster Shot
For healthy individuals, doctors advise considering the timing of their vaccination. Many experts suggest it might be beneficial to wait until the fall for a booster. This strategy aims to maximize protection during the anticipated winter surge, ensuring immunity is strongest when most needed. However, individuals at higher risk of complications, such as older adults or those with weakened immune systems, should consult their doctors to determine the optimal vaccination schedule for their specific needs.
Essential Everyday Prevention
Beyond vaccination, foundational public health measures remain effective year-round in mitigating the spread of respiratory viruses:
Spend Time Outdoors: When possible, gathering in open-air environments reduces transmission risk.
Practice Diligent Handwashing: Frequent and thorough handwashing with soap and water is crucial.
Consider Masking: Wear a mask in crowded indoor settings or when advised by local health authorities.
- Stay Home When Sick: This is perhaps the most critical measure to prevent onward transmission.
- abc7.com
- www.nbcnews.com
- whyy.org
The Evolving Landscape of COVID-19 Seasonality
While we traditionally associate colds and flu with colder months, COVID-19 has demonstrated a less predictable seasonality. Recent years have seen late summer surges, and federal data confirms a current upward trend in cases across most U.S. states. This phenomenon is largely influenced by human behavior rather than just weather. When temperatures soar, people often seek refuge in air-conditioned indoor spaces, paradoxically creating environments ripe for germ spread. This increased indoor congregation ironically turns summer into a “cold season” in some consistently hot regions.
The Centers for Disease Control and Prevention (CDC) has also noted a rise in emergency room visits for COVID-19 among children younger than four. This trend is particularly concerning, as many young children may be experiencing the virus for the first time or remain unvaccinated, highlighting their vulnerability in the face of evolving variants and changing public health guidance.
Frequently Asked Questions
What are the key characteristics of the NB.1.8.1 COVID variant?
The NB.1.8.1 variant is a new Omicron sub-strain first identified by Stanford University scientists, originating in China. Its most notable characteristic is its significantly increased transmissibility due to a greater ability to attach to human cells. Crucially, health experts and the WHO have found no evidence that NB.1.8.1 causes more severe illness or is better at evading protection from existing vaccines compared to prior dominant strains. It has been detected in California wastewater samples and in other U.S. states.
Should healthy individuals delay their next COVID-19 booster shot?
For healthy individuals, some doctors suggest considering a booster shot in the fall, rather than immediately. This approach aims to maximize protection during the anticipated winter “respiratory season,” when COVID-19 cases are predicted to surge. However, individuals at higher risk of complications from COVID-19, such as older adults or those with underlying health conditions, should consult their healthcare provider to determine the best and most timely vaccination schedule for their specific health needs.
How have recent policy changes impacted COVID-19 vaccine recommendations for vulnerable groups?
Recent reports indicate that Health and Human Services Secretary Robert F. Kennedy Jr. has removed the COVID-19 vaccine from the CDC’s immunization schedule for pregnant women and healthy children. Additionally, the FDA plans to limit updated COVID-19 shot approvals to older adults and younger individuals with specific medical conditions. Infectious disease experts express significant concern, highlighting the potential loss of crucial antibody protection for infants from vaccinated mothers and increased vulnerability for young children and pregnant individuals.
Staying Vigilant in a Changing Landscape
The emergence of the NB.1.8.1 variant in California serves as a stark reminder that the COVID-19 virus continues to evolve and challenge public health. While this new variant is highly contagious, it does not appear to cause more severe illness. However, shifting public health policies regarding vaccine recommendations for vulnerable populations have introduced new complexities and concerns for experts. By staying informed, continuing to practice preventative measures, and making educated decisions about vaccination in consultation with healthcare professionals, individuals can play a vital role in protecting themselves and their communities against ongoing threats.
